Try
10x Genomics Inc. Class A Common Stock
TXGUnited States
34 filed reports · 377 financial concepts · 1 earnings calls · 2 media appearances
Filed reports
34 reports · Sep 2019 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 14 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 21 | 3,781 | Sep 2019 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 7 | 3,331 | Dec 2019 to Dec 2025 |
| Current · 8-KSEC EDGAR | 6 | 14 | Sep 2019 to Jun 2026 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 7, 2026 | 376 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 6, 2026 | 4 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 8, 2026 | 234 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 13, 2026 | 881 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 7, 2025 | 258 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 8, 2025 | 152 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 9, 2025 | 149 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 13, 2025 | 438 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Oct 29, 2024 | 165 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 8, 2024 | 150 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | Apr 30, 2024 | 160 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 15, 2024 | 431 | Open |
Financial data
377 concepts · 7,126 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial373 concepts · 6,613 facts · Dec 2017 to Jun 2026
- Accrued legal and related costs44 · Dec 2018 to Jun 2026
- Stockholders equity (US GAAP)44 · Dec 2017 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value43 · Dec 2017 to Jun 2026
- Gross profit (US GAAP)43 · Dec 2017 to Jun 2026
- Net income loss43 · Dec 2017 to Jun 2026
- Other comprehensive income loss net of tax portion attributable to parent43 · Dec 2017 to Jun 2026
- Revenue43 · Dec 2017 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents42 · Dec 2017 to Jun 2026
- Allocated share based compensation expense41 · Dec 2017 to Jun 2026
- Comprehensive income net of tax41 · Dec 2017 to Jun 2026
- Cost of revenue (US GAAP)41 · Dec 2017 to Jun 2026
- Income tax expense benefit41 · Dec 2017 to Jun 2026
- Investment income interest41 · Dec 2017 to Jun 2026
- Nonoperating income expense41 · Dec 2017 to Jun 2026
- Operating expenses (US GAAP)41 · Dec 2017 to Jun 2026
- Operating income loss41 · Dec 2017 to Jun 2026
- Other nonoperating income expense41 · Dec 2017 to Jun 2026
- Research and development expense excluding acquired in process cost41 · Dec 2017 to Jun 2026
- Selling general and administrative expense41 · Dec 2017 to Jun 2026
- Accrued expenses and other current liabilities40 · Dec 2017 to Jun 2026
- Capital expenditures incurred but not yet paid40 · Dec 2017 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect40 · Dec 2017 to Jun 2026
- Depreciation depletion and amortization40 · Dec 2017 to Jun 2026
- Effect of exchange rate on cash cash equivalents restricted cash and restricted cash equivalents40 · Dec 2017 to Jun 2026
Geography1 concepts · 253 facts · Dec 2017 to Jun 2026
- Revenue253 · Dec 2017 to Jun 2026
Product1 concepts · 246 facts · Dec 2017 to Jun 2026
- Revenue246 · Dec 2017 to Jun 2026
Guidance2 concepts · 14 facts · Nov 2019 to Aug 2026
- Revenue Guidance12 · Nov 2019 to Aug 2026
- Revenue Growth Guidance2 · Aug 2026
Segments
499 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement geographical9 members · 253 facts
- CN41 · Dec 2017 to Jun 2026
- EMEA41 · Dec 2017 to Jun 2026
- Asia Pacific37 · Dec 2017 to Jun 2026
- Asia Pacific Excluding China30 · Mar 2020 to Jun 2026
- US29 · Dec 2019 to Jun 2026
- Americas23 · Dec 2021 to Jun 2026
- Americas Excluding United States23 · Dec 2021 to Jun 2026
- North America17 · Dec 2017 to Sep 2021
- North America Excluding United States12 · Dec 2019 to Dec 2022
Product or service12 members · 246 facts
- Consumables41 · Dec 2017 to Jun 2026
- Service41 · Dec 2017 to Jun 2026
- Instruments32 · Jun 2019 to Jun 2026
- Spatial Consumables23 · Dec 2021 to Jun 2026
- Spatial Instruments23 · Dec 2021 to Jun 2026
- Chromium Consumables21 · Dec 2021 to Jun 2026
- Chromium Instruments21 · Dec 2021 to Jun 2026
- Licensing And Royalty Revenue13 · Dec 2023 to Jun 2026
- Product And Service Revenue13 · Dec 2023 to Jun 2026
- Instuments12 · Dec 2017 to Dec 2022
- Single Cell Consumables3 · Dec 2023 to Dec 2025
- Single Cell Instruments3 · Dec 2023 to Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary84 claims from 11 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary142 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes15 claims from 1 reports · Dec 2025
- Risk factors140 risks from 2 annual reports · 2024 to 2025
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
Executive media
2 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- Other appearances1 · Apr 2026
- TV interviews1 · Oct 2020
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.